ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,57
-0,56%
Dow Jones
39 150,33
0,04%
DAX
18 163,52
-0,41%
Brent Oil
84,39
0,00%
Bitcoin
64 085,04
-0,25%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Fulcrum Therapeutics Inc (FULC)

  7. Fulcrum Therapeutics Inc (FULC) Actualités

FULC

Fulcrum Therapeutics (FULC)

Fulcrum Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FULC
DateHeureSourceTitreSymboleSociété
18/06/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
17/06/202422h37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
13/05/202413h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
09/03/202400h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
27/02/202423h18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FULCFulcrum Therapeutics Inc
27/02/202423h12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FULCFulcrum Therapeutics Inc
27/02/202422h01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FULCFulcrum Therapeutics Inc
22/08/202313h48Dow Jones NewsFulcrum Therapeutics Shares Rally Premarket as FDA Lifts Study HoldNASDAQ:FULCFulcrum Therapeutics Inc
11/08/202322h53GlobeNewswire Inc.Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FULCFulcrum Therapeutics Inc
03/07/202322h16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
29/06/202322h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
26/06/202312h01Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FULCFulcrum Therapeutics Inc
23/06/202311h45PR Newswire (US)FULC SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulcrum Shareholders of a Lead Plaintiff Deadline of June 27, 2023NASDAQ:FULCFulcrum Therapeutics Inc
21/06/202311h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulcrum Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 27, 2023 - (NASDAQ: FULC)NASDAQ:FULCFulcrum Therapeutics Inc
20/06/202313h00GlobeNewswire Inc.Advocacy and Industry Partners Launch New Global Coalition to Speed Delivery of New Therapies for Facioscapulohumeral Muscular Dystrophy (FSHD)NASDAQ:FULCFulcrum Therapeutics Inc
09/06/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FULCFulcrum Therapeutics Inc
15/05/202313h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FULCFulcrum Therapeutics Inc
28/04/202322h22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FULCFulcrum Therapeutics Inc
28/04/202322h13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FULCFulcrum Therapeutics Inc
09/03/202314h28Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FULCFulcrum Therapeutics Inc
06/03/202322h41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FULCFulcrum Therapeutics Inc
24/02/202314h56Dow Jones NewsFulcrum Therapeutics Shares Plummet as FDA Puts Sickle-Cell Study on HoldNASDAQ:FULCFulcrum Therapeutics Inc
14/02/202322h27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FULCFulcrum Therapeutics Inc
18/01/202305h15GlobeNewswire Inc.Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common StockNASDAQ:FULCFulcrum Therapeutics Inc
17/01/202322h01GlobeNewswire Inc.Fulcrum Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:FULCFulcrum Therapeutics Inc
04/01/202313h02GlobeNewswire Inc.Fulcrum Therapeutics Provides Business Update and 2023 OutlookNASDAQ:FULCFulcrum Therapeutics Inc
04/01/202313h01GlobeNewswire Inc.Fulcrum Therapeutics Announces CEO TransitionNASDAQ:FULCFulcrum Therapeutics Inc
01/12/202222h01GlobeNewswire Inc.Fulcrum Therapeutics to Participate at Upcoming 2022 BofA Securities Biotech SMID Cap ConferenceNASDAQ:FULCFulcrum Therapeutics Inc
16/11/202201h11TipRanksFULC, CMBM: 2 Underdog Stocks That Deserve Attention Right NowNASDAQ:FULCFulcrum Therapeutics Inc
14/11/202217h35TipRanksMorgan Stanley Sticks to Their Buy Rating for Fulcrum Therapeutics (FULC)NASDAQ:FULCFulcrum Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FULC

Dernières Valeurs Consultées

TSX
PVS.PR.K
Partners Value Split
BOV
LAND3Q
Terra Santa Propriedades... ON
ASX
BEO
Beonic
TSX
STLR
STLLR Gold
UNSW3
FODLETH
Fodl
BIT
P10MQ3
Bnp Paribas Issuance
TG
2XOA
Coca Cola HBC Finance BV
LSE
BC68
Greek 5%1907
NASDAQ
ADLR
TG
933B
Cellnex Telecom
TG
O3H
Sia Engineering
USOTC
BLMMF
Blackmores (PK)
LSE
57UT
Grand Union 43
BIT
P1WKN7
NLBNPIT1WKN7 20351221 10...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés